Provided by Tiger Trade Technology Pte. Ltd.

Tyra Biosciences, Inc.

22.03
-1.5100-6.41%
Pre-market: 22.470.4425+2.01%08:11 EDT
Volume:1.55M
Turnover:35.06M
Market Cap:1.31B
PE:-9.17
High:23.96
Open:23.63
Low:21.86
Close:23.54
52wk High:40.65
52wk Low:11.82
Shares:59.49M
Float Shares:35.21M
Volume Ratio:0.64
T/O Rate:4.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4031
EPS(LYR):-2.0125
ROE:-45.31%
ROA:-28.46%
PB:3.71
PE(LYR):-10.95

Loading ...

Nov 03, 2021

Major Issues Report

8-K - Current report
Nov 03, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 29, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 27, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Sep 27, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Sep 27, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 24, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Sep 21, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 17, 2021

Major Issues Report

8-K - Current report
Sep 15, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Sep 14, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 10, 2021

Correspondence

CORRESP [Cover] - Correspondence
Sep 10, 2021

Correspondence

CORRESP [Cover] - Correspondence
Sep 09, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Aug 20, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Aug 20, 2021

Correspondence

CORRESP [Cover] - Correspondence
Aug 20, 2021

Correspondence

CORRESP [Cover] - Correspondence